RO122491B1 - Derivaţi de benzimidazol, alcoxi substituiţi, compoziţii farmaceutice care îi conţin şi utilizarea acestora - Google Patents

Derivaţi de benzimidazol, alcoxi substituiţi, compoziţii farmaceutice care îi conţin şi utilizarea acestora Download PDF

Info

Publication number
RO122491B1
RO122491B1 ROA200200206A RO200200206A RO122491B1 RO 122491 B1 RO122491 B1 RO 122491B1 RO A200200206 A ROA200200206 A RO A200200206A RO 200200206 A RO200200206 A RO 200200206A RO 122491 B1 RO122491 B1 RO 122491B1
Authority
RO
Romania
Prior art keywords
methoxy
compounds
formula
pyridinyl
benzimidazole
Prior art date
Application number
ROA200200206A
Other languages
English (en)
Romanian (ro)
Inventor
Robert R. Whittle
Frederick D. Sancilio
Grayson Walker Stowell
Douglas John Jenkins
Linda Whittall
Glenn Alan Meyer
Steven A. Fontana
Original Assignee
Applied Analytical Industries, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/519,976 external-priority patent/US6262085B1/en
Application filed by Applied Analytical Industries, Inc. filed Critical Applied Analytical Industries, Inc.
Publication of RO122491B1 publication Critical patent/RO122491B1/ro

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
ROA200200206A 1999-08-26 2000-08-25 Derivaţi de benzimidazol, alcoxi substituiţi, compoziţii farmaceutice care îi conţin şi utilizarea acestora RO122491B1 (ro)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15087899P 1999-08-26 1999-08-26
US09/519,976 US6262085B1 (en) 1999-08-26 2000-03-07 Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
PCT/US2000/023363 WO2001014367A1 (en) 1999-08-26 2000-08-25 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same

Publications (1)

Publication Number Publication Date
RO122491B1 true RO122491B1 (ro) 2009-07-30

Family

ID=26848119

Family Applications (1)

Application Number Title Priority Date Filing Date
ROA200200206A RO122491B1 (ro) 1999-08-26 2000-08-25 Derivaţi de benzimidazol, alcoxi substituiţi, compoziţii farmaceutice care îi conţin şi utilizarea acestora

Country Status (16)

Country Link
EP (1) EP1206466B1 (de)
JP (1) JP4312405B2 (de)
KR (1) KR100712039B1 (de)
CN (2) CN1636564A (de)
AT (1) ATE306483T1 (de)
AU (2) AU777667B2 (de)
BR (1) BR0014145A (de)
CA (1) CA2382867A1 (de)
DE (1) DE60023154T2 (de)
HR (1) HRP20020174A2 (de)
MX (1) MXPA02002007A (de)
NO (1) NO326849B1 (de)
RO (1) RO122491B1 (de)
RU (1) RU2263673C2 (de)
SI (1) SI20974A (de)
SK (1) SK286903B6 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2376231A (en) * 2001-06-06 2002-12-11 Cipla Ltd Benzimidazole-cyclodextrin inclusion complex
CN1972928A (zh) * 2004-06-24 2007-05-30 阿斯利康(瑞典)有限公司 制备用于制备依美拉唑钠盐的结晶修饰物的新方法
ES2246149B1 (es) * 2004-07-02 2007-06-01 Esteve Quimica, S.A. Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.
CN103524491A (zh) * 2013-10-16 2014-01-22 江南大学 埃索美拉唑镁盐四水合物的三种晶型及其制备方法
CN114558004B (zh) * 2022-03-29 2023-08-11 奎马特里克斯有限公司 Qtx125药物制剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds

Also Published As

Publication number Publication date
AU777667B2 (en) 2004-10-28
CA2382867A1 (en) 2001-03-01
CN1636564A (zh) 2005-07-13
CN1384831A (zh) 2002-12-11
AU7073700A (en) 2001-03-19
JP2003507475A (ja) 2003-02-25
SI20974A (sl) 2003-02-28
SK2812002A3 (en) 2002-07-02
NO20020914D0 (no) 2002-02-25
NO326849B1 (no) 2009-03-02
JP4312405B2 (ja) 2009-08-12
EP1206466B1 (de) 2005-10-12
AU2005200203A1 (en) 2005-02-10
BR0014145A (pt) 2002-05-14
DE60023154D1 (de) 2006-02-23
MXPA02002007A (es) 2003-08-20
KR100712039B1 (ko) 2007-04-27
AU2005200203B2 (en) 2008-01-10
DE60023154T2 (de) 2006-06-22
RU2263673C2 (ru) 2005-11-10
EP1206466A1 (de) 2002-05-22
HRP20020174A2 (en) 2005-12-31
KR20020035861A (ko) 2002-05-15
SK286903B6 (sk) 2009-07-06
CN1183127C (zh) 2005-01-05
ATE306483T1 (de) 2005-10-15
NO20020914L (no) 2002-04-26

Similar Documents

Publication Publication Date Title
US6444689B1 (en) Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6268385B1 (en) Dry blend pharmaceutical formulations
WO2001014367A1 (en) Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6262086B1 (en) Pharmaceutical unit dosage form
US6326384B1 (en) Dry blend pharmaceutical unit dosage form
JP2011507977A (ja) （ｒ）−２−［［［３−メチル−４−（２，２，２−トリフルオロエトキシ）−２−ピリジニル］メチル］スルフィニル］−１ｈ−ベンズイミダゾールの溶媒和物結晶形
ES2638463T3 (es) Cristal de compuesto de bencimidazol
US6312723B1 (en) Pharmaceutical unit dosage form
JP2004526786A (ja) オメプラゾールの結晶型
AU2005200203B2 (en) Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6316020B1 (en) Pharmaceutical formulations
US6312712B1 (en) Method of improving bioavailability
WO2006132217A1 (ja) ベンズイミダゾール化合物の塩の結晶
EP1595879A2 (de) Alkoxy-substituierte Benzimidazolverbindungen, diese enthaltende Arzneimittel und ihre Verwendung